Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 88

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 88
---
 by Dr. Malik directly.

(13) Based on a Schedule 13D/A filed with the SEC on April 10, 2024 and other information known to us, consists of (i) 66,977 shares of Common Stock held by Dr. Singer directly, (ii) 383,796 shares of Common Stock held by Thirsty Brook 2010 Irrevocable Trust, a trust for which Dr. Singer is a trustee, that Dr. Singer has the right to acquire pursuant to a right of substitution in exchange for assets with an equal value to such shares, (iii) 56,719 shares of Common Stock held by Singer Asefzadeh Family Holding Trust, a trust for which Dr. Singer is a trustee and beneficiary, (iv) 7,127 shares of Common Stock held by Bakezilla 2019 Irrevocable Trust, a trust for which Dr. Singer is a trustee and beneficiary, (v) 14,788 shares of Common Stock held by Dr. Baharak Asefzadeh, Dr. Singer’s spouse, (vi) 96,219 shares of Common Stock held by a minor child of Dr. Singer through a custodial account established pursuant to the Uniform Transfer to Minors Act (“UTMA”) for which Dr. Singer serves as custodian, (vii) 96,219 shares of Common Stock held by a minor child of Dr. Singer through a custodial account established pursuant to the UTMA for which Dr. Singer serves as custodian, and (viii) 3,588 shares of Common Stock issuable upon exercise of outstanding options within 60 days of April 14, 2025 held by Dr. Singer directly.

(14) Consists of 3,818 shares of Common Stock held by Mr. Zenner directly and (ii) 3,588 shares of Common Stock underlying outstanding stock options exercisable within 60 days of April 14, 2025.

(15) Includes (i) 15,527,159 shares of Common Stock owned directly or beneficially by our executive officers or members of our Board, (ii) 549,625 shares of Common Stock underlying outstanding stock options and warrants exercisable within 60 days of April 14, 2025, and (iii) 126,002 shares of Common Stock issuable upon conversion of the shares of Series A Preferred Stock.

<div align='center'>52</div>

#### Delinquent Section 16(a